drugset / Trial / NCT03316534

Effect of Aspirin on Abacavir-induced Platelet Reactivity in HIV-infected Patients

NCT03316534

Phase 2 Completed 40 enrolled Azienda Ospedaliera di Perugia
RandomizedCrossoverDouble-blindPrevention

Summary

The specific research questions addressed in the present study are: * to investigate the impact of treatment with low-dose aspirin in HIV-1-infected patients treated with ABC and test it would result in decreased in vivo platelet activation and platelet hyperreactivity * to investigate if aspirin has the same effects in HIV-infected as in HIV-uninfected patients.

Timeline

Start
2017-01-02
Primary completion
2017-04-30
Completion
2017-10-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Aspirin Small molecule 100 mg

Indications

No indication recorded.